Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1207 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Medivir plans to buy BioPhausia

In line with its strategy, the acquisition expands Medivir’s commercial activities in the Nordic countries and creates the platform for the expected launch and commercialization of TMC435. BioPhausia

Cellmid reveals MK preclinical trial results

The study results suggested that MK has showed 27% reduction in the area of heart muscle damage as compared to untreated animals undergoing the same procedure. Dose-ranging studies

UK grants funding to Biocontrol

As part of the £4.5m, eleven project initiative, this specific project will fund a consortium of five industrial and academic partners led by Unilever. During the three year

Prana Biotechnology receives Japanese patent

The patent entitled ‘8-Hydroxyquinoline derivatives’ also covers pharmaceutical compositions containing PBT2 and selected 8-hydroxyquinoline compounds and the use of the compounds for the treatment of Alzheimer’s disease. Prana

J&JPRD schizophrenia drug obtains FDA approval

A six-week randomized, double-blind, placebo-controlled study evaluated the safety and efficacy Invega in schizophrenia patients and showed efficacy in adolescents with the dose range of 3 to 12